Metastases to bone and Failure to thrive
Summary:
Failure to thrive is found among people with Metastases to bone, especially for people who are female, 60+ old.
The study analyzes which people have Failure to thrive with Metastases to bone. It is created by eHealthMe based on reports of 62 people who have Metastases to bone from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.
What is Metastases to bone?
Metastases to bone (cancer spreads to bone) is found to be associated with 1,127 drugs and 902 conditions by eHealthMe. Check the latest studies of Metastases to bone.
What is Failure to thrive?
Failure to thrive (inadequate weight gain and physical growth in children) is found to be associated with 772 drugs and 1,167 conditions by eHealthMe. Check the latest studies of Failure to thrive.
62 people who have Metastases To Bone and Failure To Thrive are studied.

Gender of people who have Metastases To Bone and experienced Failure To Thrive *:
- female: 56.67 %
- male: 43.33 %
Age of people who have Metastases To Bone and experienced Failure To Thrive *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 2.27 %
- 30-39: 2.27 %
- 40-49: 20.45 %
- 50-59: 22.73 %
- 60+: 52.27 %
Common co-existing conditions for these people *:
- Osteoporosis (bones weak and more likely to break): 9 people, 14.52%
- Neoplasm Malignant (cancer tumour): 9 people, 14.52%
- Breast Cancer: 7 people, 11.29%
- Prostate Cancer: 6 people, 9.68%
- Multiple Myeloma (cancer of the plasma cells): 5 people, 8.06%
- High Blood Cholesterol: 4 people, 6.45%
- Glaucoma (increased fluid pressure in the eye with vision loss): 4 people, 6.45%
- Stomatitis (inflammation of mucous membrane of mouth): 4 people, 6.45%
- Constipation: 4 people, 6.45%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 6.45%
Common drugs taken by these people *:
- Zometa: 47 people, 75.81%
- Aredia: 47 people, 75.81%
- Lorazepam: 28 people, 45.16%
- Celebrex: 22 people, 35.48%
- Dexamethasone: 19 people, 30.65%
- Oxycontin: 19 people, 30.65%
- Lasix: 18 people, 29.03%
- Taxotere: 17 people, 27.42%
- Decadron: 17 people, 27.42%
- Xeloda: 17 people, 27.42%
Common symptoms for these people *:
- Osteonecrosis Of Jaw (death of bone of jaw): 48 people, 77.42%
- Stress And Anxiety: 43 people, 69.35%
- Nausea (feeling of having an urge to vomit): 37 people, 59.68%
- Osteomyelitis (infection of bone): 36 people, 58.06%
- Pain: 36 people, 58.06%
- Dyspnea (difficult or laboured breathing): 32 people, 51.61%
- Constipation: 31 people, 50.00%
- Back Pain: 31 people, 50.00%
- Weakness: 29 people, 46.77%
- Oedema Peripheral (superficial swelling): 28 people, 45.16%
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Failure to thrive?
- Check whether Failure to thrive is associated with a drug or a conditionRelated studies:
Treatments, associated drugs and conditions:
- Metastases to bone (51,059 reports)
- Failure to thrive (8,077 reports)
All the drugs that are associated with Failure to thrive:
- Failure to thrive (772 drugs)
All the conditions that are associated with Failure to thrive:
- Failure to thrive (1,167 conditions)
How the study uses the data?
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
The study is based on Failure to thrive and Metastases to bone, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Ibuprofen cause Apnoeic Attack? - 24 seconds ago
- Paroxetine vs. Clonidine, side effect and effectiveness comparison - 24 seconds ago
- Could Pamelor cause Restless Leg Syndrome? - 29 seconds ago
- Could Astragalus cause Urinary Tract Infection? - 35 seconds ago
- Drug interactions of Truvada and Ciprofloxacin - 47 seconds ago
- Pulmonary Embolism and Large Intestinal Ulcer Haemorrhage - 51 seconds ago
- Could Dexamethasone Sodium Phosphate cause Stomatitis? - a minute ago
- Could Depo-Provera cause Infusion Site Bruising? - a minute ago
- Drug interactions of Amoxicillin and Ibu - a minute ago
- Drug interactions of Normodyne and Maxzide - a minute ago